Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belimumab Continuation Study in SLE (BEL114333)
NCT01597622Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2012
- Primary completion
- Sep 2018
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of belimumab in systemic lupus erythematosus (SLE), sponsored by GSK. Started Jun 2012; status: completed.
02
Drugs
belimumab
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT01597622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01597622.